BETA - Pilot Study

Part of paid clinical trials in San Francisco, California.

Sponsor
4YouandMe
Study ID
NCT07192861
Status
Enrolling By Invitation

Conditions

  • Diabetes (DM)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This study is testing the feasibility of using non-invasive, remote digital tools including continuous glucose monitors (CGMs) and Oura ring and the Empatica EmbracePlus smart wristband to predict the function of beta-cells, the cells in the pancreas that secrete insulin. This study is being initially done with individuals with Type 1 diabetes, so that in the future these methods can be tested in a larger study of individuals with Type 2 diabetes or prediabetics. The eventual aim of this work is to develop remote digital tools that can predict the health and functioning of the pancreas in people with prediabetes and Type 2 diabetes, allowing personalized treatment approaches to preserve insulin secretion.

Key Dates

Start date
Jul 1, 2025
Status verified
Sep 2025
Primary completion
Nov 30, 2025
Completion
Nov 30, 2025

Study Design

Enrollment
28 participants (estimated)

Primary Outcome Measure

Feasibility: Retention [ Time Frame: 6 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Buck Institute for Research on AgingSan FranciscoCalifornia94102-

Find similar trials in San Francisco, CA

By research site
Buck Institute for Research on Aging· San Francisco, CA

Related Studies